Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€81.34

€81.34

0.590%
0.48
0.590%
€100.00
 
17:01 / Tradegate WKN: 915119 / Symbol: DOX / Name: Amdocs / Stock / Software & IT Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Amdocs Ltd. Stock

Amdocs Ltd. gained 0.590% compared to yesterday.
Amdocs Ltd. is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
As a result the target price of 100 € shows a positive potential of 22.94% compared to the current price of 81.34 € for Amdocs Ltd..

Pros and Cons of Amdocs Ltd. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Amdocs Ltd. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Amdocs Ltd. 0.590% 1.227% -5.360% -3.254% 1.736% 25.132% 71.568%
LivePerson Inc. 1.580% -13.630% -50.879% -89.951% -86.267% -98.998% -98.211%
Qualys Inc. 0.340% 5.015% 4.365% 40.588% -10.653% 88.338% 114.142%
Proto Labs Inc. 0.600% 1.488% -6.774% 14.242% -16.667% -66.960% -70.060%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-16

Upon first glance, the financials of Amdocs (DOX), a prominent player in the Software & IT Services industry, seem to be in decent shape. The company's total assets, revenue, and net income show signs of growth over time. However, a more in-depth examination of the company's financial performance is essential to derive valuable insights and establish the financial health of the organization.

Increasing revenue: Amdocs’ total revenue has been on an upward trajectory from 2020 to 2022, which is a positive indicator of the firm's ability to generate business and maintain client relationships. It signifies that the firm is thriving in its market and efficiently capitalizing on opportunities to generate revenues.

Rising net income: Net income has demonstrated growth over the past few years, reaching its peak in 2021. This growth in profits is suggestive of the company’s success in balancing its expenses and generating a higher return on its investments.

Comments

Amdocs Limited (NASDAQ: DOX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for DOX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -1.49%
Target price 106.686
Change
Ends at 08.02.25

Amdocs Limited (NASDAQ: DOX) had its price target raised by analysts at Barclays PLC from $105.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for DOX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -1.70%
Target price 95.701
Change
Ends at 17.01.25

Amdocs Limited (NASDAQ: DOX) had its price target raised by analysts at Citigroup Inc. from $96.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for DOX provided by MarketBeat
Show more